Concepedia

Katherine Deland

KD

6

Publications

123

Citations

6

H-Index

2012

Active since

Affiliations

Duke Medical Center(Current)

Duke University Hospital

Lurie Children's Hospital

Northwestern University

Duke University

Katherine Deland is an author at Duke Medical Center specializing in cell biology, medicine, and tumor biology.

ORCID

Top concepts

Publications per year

2012–2024

6

Publications

6

Tumor genotype dictates radiosensitization after Atm deletion in primary brainstem glioma models

Katherine Deland, Bryce Starr, Joshua S. Mercer et al. · Journal of Clinical Investigation · 2020 · 40 citations · Full text

, , +21

Atrx deletion impairs CGAS/STING signaling and increases sarcoma response to radiation and oncolytic herpesvirus

Warren Floyd, Matthew Pierpoint, Chang Su et al. · Journal of Clinical Investigation · 2023 · 27 citations · Full text

, , +14

A Novel Dual ATM/DNA-PK Inhibitor, XRD-0394, Potently Radiosensitizes and Potentiates PARP and Topoisomerase I Inhibitors

Tona M. Gilmer, Chun-Hsiang Lai, Kexiao Guo et al. · Molecular Cancer Therapeutics · 2024 · 22 citations · Full text

Exo1 plays a major role in DNA end resection in humans and influences double-strand break repair and damage signaling decisions

Nozomi Tomimatsu, Bipasha Mukherjee, Katherine Deland et al. · DNA repair · 2012 · 14 citations · Full text

, , +10

Radiosensitizing the Vasculature of Primary Brainstem Gliomas Fails to Improve Tumor Response to Radiation Therapy

Katherine Deland, Joshua S. Mercer, Donna Crabtree et al. · International Journal of Radiation Oncology*Biology*Physics · 2021 · 10 citations · Full text

Rows per page

1–5 of 6